ANGLE PLC (GB:AGL)
LSE:AGL

ANGLE plc (GB:AGL) Stock Price & Analysis

2 Followers

AGL Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range22.20p - 163.75p
Previous Close29.5p
Volume1.47M
Average Volume (3M)2.44M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-4.6
Beta0.32
Next EarningsApr 27, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-0.07
Shares Outstanding260,580,547
R-Squared0.03
Standard Deviation0.19
10 Day Avg. Volume2,099,199
30 Day Avg. Volume2,439,731
Price to Book (P/B)2.47
Price to Sales (P/S)40403.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-7.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside306.78% Upside
Rating ConsensusModerate Buy
Alpha0.02
Number of Analyst Covering1


AGL FAQ

What was ANGLE plc’s price range in the past 12 months?
ANGLE plc lowest stock price was 22.20p and its highest was 163.75p in the past 12 months.
    What is ANGLE plc’s market cap?
    Currently, no data Available
    When is ANGLE plc’s upcoming earnings report date?
    ANGLE plc’s upcoming earnings report date is Apr 27, 2023 which is in 89 days.
      How were ANGLE plc’s earnings last quarter?
      ANGLE plc released its earnings results on Sep 29, 2022. The company reported -0.035p earnings per share for the quarter, missing the consensus estimate of N/A by -0.035p.
        Is ANGLE plc overvalued?
        According to Wall Street analysts ANGLE plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ANGLE plc pay dividends?
          ANGLE plc does not currently pay dividends.
          What is ANGLE plc’s EPS estimate?
          ANGLE plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ANGLE plc have?
          ANGLE plc has 260,580,540 shares outstanding.
            What happened to ANGLE plc’s price movement after its last earnings report?
            ANGLE plc reported an EPS of -0.035p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.781%.
              Which hedge fund is a major shareholder of ANGLE plc?
              Currently, no hedge funds are holding shares in GB:AGL

              ---

              ANGLE plc Stock Smart Score

              2
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -75.21%
              12-Months-Change

              Fundamentals

              Return on Equity
              -55.77%
              Trailing 12-Months
              Asset Growth
              20.29%
              Trailing 12-Months
              The ANGLE plc Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              ANGLE PLC

              ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology has the potential to treat and diagnose the various forms of cancer. The Parsortix system can capture and harvest (Circulating Tumor Cells)CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of the revenue is generated from Europe.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Smith & Nephew
              EKF Diagnostics Holdings
              Advanced Oncotherapy
              LivaNova

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis